Farrell Michael J.
SEC CIK 1485164 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RMD | ResMed| | COB, CEO, Dir | 471.2K | — | $85.18M | 127 | 2021-08-19 | 2026-09-08 |
Most active insiders at RMD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Farrell Michael J. | COB, CEO, Dir | — | $15.74M |
| 2 | FARRELL PETER C | Dir | — | $5.01M |
| 3 | Sandercock Brett | CFO | — | $2.79M |
| 4 | De Witte Jan | Dir | — | $645.9K |
| 5 | Rider Michael J | Gbl GC | — | $64.7K |
| 6 | Mowad-Nassar Nicole | Dir | — | — |
| 7 | Hernandez John | Dir | — | — |
| 8 | Tan Desney | Dir | — | — |
| 9 | DelOrefice Christopher | Dir | — | — |
| 10 | Leong Justin | Chief Product Off | — | — |
Transactions 127
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-09-10 06:40 | 2026-09-08 | RMD | ResMed| | Farrell Michael J. | COB, CEO, Dir | M - OptEx | $146.34 | +4,991 | 471.2K | +1% | +$730.4K |
| DT | 2026-09-10 06:40 | 2026-09-08 | RMD | ResMed| | Farrell Michael J. | COB, CEO, Dir | S - Sale+OE | $222.44 | -4,991 | 466.3K | -1% | -$1.11M |
| DT | 2026-08-11 06:30 | 2026-08-07 | RMD | ResMed| | Farrell Michael J. | COB, CEO, Dir | M - OptEx | $146.34 | +4,991 | 471.2K | +1% | +$730.4K |
| DT | 2026-08-11 06:30 | 2026-08-07 | RMD | ResMed| | Farrell Michael J. | COB, CEO, Dir | S - Sale+OE | $205.69 | -4,991 | 466.3K | -1% | -$1.03M |
| DT | 2026-07-09 07:40 | 2026-07-07 | RMD | ResMed| | Farrell Michael J. | COB, CEO, Dir | M - OptEx | $146.34 | +4,991 | 471.2K | +1% | +$730.4K |
| DT | 2026-07-09 07:40 | 2026-07-07 | RMD | ResMed| | Farrell Michael J. | COB, CEO, Dir | S - Sale+OE | $218.55 | -4,991 | 466.2K | -1% | -$1.09M |
| DT | 2026-06-09 14:26 | 2026-06-08 | RMD | ResMed| | Farrell Michael J. | COB, CEO, Dir | M - OptEx | $146.34 | +4,991 | 471.2K | +1% | +$730.4K |
| DT | 2026-06-09 14:26 | 2026-06-08 | RMD | ResMed| | Farrell Michael J. | COB, CEO, Dir | S - Sale+OE | $193.96 | -4,991 | 466.3K | -1% | -$968.1K |
| DT | 2026-05-11 07:33 | 2026-05-07 | RMD | ResMed| | Farrell Michael J. | COB, CEO, Dir | M - OptEx | $146.34 | +4,991 | 471.2K | +1% | +$730.4K |
| DT | 2026-05-11 07:33 | 2026-05-07 | RMD | ResMed| | Farrell Michael J. | COB, CEO, Dir | S - Sale+OE | $207.82 | -4,991 | 466.2K | -1% | -$1.04M |
| DT | 2026-04-09 11:44 | 2026-04-07 | RMD | ResMed| | Farrell Michael J. | COB, CEO, Dir | M - OptEx | $146.34 | +4,991 | 471.2K | +1% | +$730.4K |
| DT | 2026-04-09 11:44 | 2026-04-07 | RMD | ResMed| | Farrell Michael J. | COB, CEO, Dir | S - Sale+OE | $225.50 | -4,991 | 466.2K | -1% | -$1.13M |
| D | 2026-03-11 | 2026-03-09 | RMD | ResMed| | Farrell Michael J. | COB, CEO, Dir | M - OptEx | $146.34 | +4,991 | 471.2K | +1% | +$730.4K |
| D | 2026-03-11 | 2026-03-09 | RMD | ResMed| | Farrell Michael J. | COB, CEO, Dir | S - Sale+OE | $251.03 | -4,991 | 466.2K | -1% | -$1.25M |
| D | 2026-02-10 | 2026-02-09 | RMD | ResMed| | Farrell Michael J. | COB, CEO, Dir | M - OptEx | $146.34 | +4,991 | 471.2K | +1% | +$730.4K |
| D | 2026-02-10 | 2026-02-09 | RMD | ResMed| | Farrell Michael J. | COB, CEO, Dir | S - Sale+OE | $273.78 | -4,991 | 466.2K | -1% | -$1.37M |
| D | 2026-01-08 | 2026-01-07 | RMD | ResMed| | Farrell Michael J. | COB, CEO, Dir | S - Sale+OE | $248.46 | -4,991 | 466.2K | -1% | -$1.24M |
| D | 2026-01-08 | 2026-01-07 | RMD | ResMed| | Farrell Michael J. | COB, CEO, Dir | M - OptEx | $146.34 | +4,991 | 471.2K | +1% | +$730.4K |
| D | 2025-12-09 | 2025-12-08 | RMD | ResMed| | Farrell Michael J. | COB, CEO, Dir | M - OptEx | $146.34 | +4,991 | 471.2K | +1% | +$730.4K |
| D | 2025-12-09 | 2025-12-08 | RMD | ResMed| | Farrell Michael J. | COB, CEO, Dir | S - Sale+OE | $251.41 | -4,991 | 466.2K | -1% | -$1.25M |
| 2025-11-24 | 2025-11-20 | RMD | ResMed| | Farrell Michael J. | COB, CEO, Dir | A - Grant | $0.00 | +13.6K | 473.5K | +3% | $0 | |
| 2025-11-24 | 2025-11-20 | RMD | ResMed| | Farrell Michael J. | COB, CEO, Dir | F - Tax | $0.00 | -7,297 | 466.2K | -2% | $0 | |
| M | 2025-11-13 | 2025-11-11 | RMD | ResMed| | Farrell Michael J. | COB, CEO, Dir | F - Tax | $250.10 | -7,897 | 460.0K | -2% | -$1.97M |
| DM | 2025-11-10 | 2025-11-07 | RMD | ResMed| | Farrell Michael J. | COB, CEO, Dir | M - OptEx | $101.64 | +8,011 | 468.8K | +2% | +$814.2K |
| D | 2025-11-10 | 2025-11-07 | RMD | ResMed| | Farrell Michael J. | COB, CEO, Dir | S - Sale+OE | $249.75 | -8,011 | 467.9K | -2% | -$2.00M |
| D | 2025-10-09 | 2025-10-07 | RMD | ResMed| | Farrell Michael J. | CEO | M - OptEx | $101.64 | +8,009 | 475.8K | +2% | +$814.0K |
| D | 2025-10-09 | 2025-10-07 | RMD | ResMed| | Farrell Michael J. | CEO | S - Sale+OE | $282.85 | -8,009 | 467.8K | -2% | -$2.27M |
| D | 2025-09-09 | 2025-09-08 | RMD | ResMed| | Farrell Michael J. | CEO | M - OptEx | $101.64 | +8,009 | 475.8K | +2% | +$814.0K |
| D | 2025-09-09 | 2025-09-08 | RMD | ResMed| | Farrell Michael J. | CEO | S - Sale+OE | $278.14 | -8,009 | 467.8K | -2% | -$2.23M |
| 2025-08-19 | 2025-08-15 | RMD | ResMed| | Farrell Michael J. | CEO | A - Grant | $0.00 | +12.3K | 467.8K | +3% | $0 | |
| D | 2025-08-11 | 2025-08-07 | RMD | ResMed| | Farrell Michael J. | CEO | M - OptEx | $101.64 | +8,009 | 463.5K | +2% | +$814.0K |
| D | 2025-08-11 | 2025-08-07 | RMD | ResMed| | Farrell Michael J. | CEO | S - Sale+OE | $279.48 | -8,009 | 455.5K | -2% | -$2.24M |
| D | 2025-07-09 | 2025-07-07 | RMD | ResMed| | Farrell Michael J. | CEO | M - OptEx | $101.64 | +8,009 | 463.5K | +2% | +$814.0K |
| D | 2025-07-09 | 2025-07-07 | RMD | ResMed| | Farrell Michael J. | CEO | S - Sale+OE | $256.72 | -8,009 | 455.5K | -2% | -$2.06M |
| D | 2025-06-10 | 2025-06-09 | RMD | ResMed| | Farrell Michael J. | CEO | S - Sale+OE | $251.21 | -8,009 | 455.5K | -2% | -$2.01M |
| D | 2025-06-10 | 2025-06-09 | RMD | ResMed| | Farrell Michael J. | CEO | M - OptEx | $101.64 | +8,009 | 463.5K | +2% | +$814.0K |
| D | 2025-05-09 | 2025-05-07 | RMD | ResMed| | Farrell Michael J. | CEO | S - Sale+OE | $243.23 | -8,009 | 455.5K | -2% | -$1.95M |
| D | 2025-05-09 | 2025-05-07 | RMD | ResMed| | Farrell Michael J. | CEO | M - OptEx | $101.64 | +8,009 | 463.5K | +2% | +$814.0K |
| D | 2025-04-09 | 2025-04-07 | RMD | ResMed| | Farrell Michael J. | CEO | M - OptEx | $101.64 | +8,009 | 463.5K | +2% | +$814.0K |
| D | 2025-04-09 | 2025-04-07 | RMD | ResMed| | Farrell Michael J. | CEO | S - Sale+OE | $209.85 | -8,009 | 455.5K | -2% | -$1.68M |
| D | 2025-03-11 | 2025-03-07 | RMD | ResMed| | Farrell Michael J. | CEO | S - Sale+OE | $229.20 | -8,009 | 455.5K | -2% | -$1.84M |
| D | 2025-03-11 | 2025-03-07 | RMD | ResMed| | Farrell Michael J. | CEO | M - OptEx | $101.64 | +8,009 | 463.5K | +2% | +$814.0K |
| D | 2025-02-11 | 2025-02-07 | RMD | ResMed| | Farrell Michael J. | CEO | S - Sale+OE | $236.77 | -8,009 | 455.5K | -2% | -$1.90M |
| D | 2025-02-11 | 2025-02-07 | RMD | ResMed| | Farrell Michael J. | CEO | M - OptEx | $101.64 | +8,009 | 463.5K | +2% | +$814.0K |
| DMI | 2024-11-27 | 2024-11-27 | RMD | ResMed| | Farrell Michael J. | CEO | G - Gift | $0.00 | 0 | 2,000 | New | $0 |
| DI | 2024-11-27 | 2024-11-27 | RMD | ResMed| | Farrell Michael J. | CEO | S - Sale | $249.67 | -2,000 | 0 | -100% | -$499.3K |
| DM | 2024-11-12 | 2024-11-11 | RMD | ResMed| | Farrell Michael J. | CEO | F - Tax | $252.38 | -8,781 | 461.2K | -2% | -$2.22M |
| D | 2024-11-12 | 2024-11-07 | RMD | ResMed| | Farrell Michael J. | CEO | S - Sale+OE | $246.26 | -14.7K | 464.3K | -3% | -$3.62M |
| D | 2024-11-12 | 2024-11-07 | RMD | ResMed| | Farrell Michael J. | CEO | M - OptEx | $84.98 | +14.7K | 478.9K | +3% | +$1.25M |
| D | 2024-10-09 | 2024-10-07 | RMD | ResMed| | Farrell Michael J. | CEO | M - OptEx | $84.98 | +14.7K | 478.9K | +3% | +$1.25M |
| D | 2024-10-09 | 2024-10-07 | RMD | ResMed| | Farrell Michael J. | CEO | S - Sale+OE | $231.91 | -14.7K | 464.2K | -3% | -$3.41M |
| D | 2024-09-10 | 2024-09-09 | RMD | ResMed| | Farrell Michael J. | CEO | M - OptEx | $84.98 | +14.7K | 478.9K | +3% | +$1.25M |
| D | 2024-09-10 | 2024-09-09 | RMD | ResMed| | Farrell Michael J. | CEO | S - Sale+OE | $248.38 | -14.7K | 464.2K | -3% | -$3.65M |
| M | 2024-08-16 | 2024-08-15 | RMD | ResMed| | Farrell Michael J. | CEO | A - Grant | $0.00 | +23.4K | 464.2K | +5% | $0 |
| D | 2024-08-09 | 2024-08-07 | RMD | ResMed| | Farrell Michael J. | CEO | M - OptEx | $84.98 | +14.7K | 455.5K | +3% | +$1.25M |
| D | 2024-08-09 | 2024-08-07 | RMD | ResMed| | Farrell Michael J. | CEO | S - Sale+OE | $214.25 | -14.7K | 440.8K | -3% | -$3.15M |
| D | 2024-07-10 | 2024-07-08 | RMD | ResMed| | Farrell Michael J. | CEO | M - OptEx | $84.98 | +14.7K | 455.5K | +3% | +$1.25M |
| D | 2024-07-10 | 2024-07-08 | RMD | ResMed| | Farrell Michael J. | CEO | S - Sale+OE | $192.97 | -14.7K | 440.8K | -3% | -$2.83M |
| D | 2024-06-10 | 2024-06-07 | RMD | ResMed| | Farrell Michael J. | CEO | S - Sale+OE | $211.66 | -14.7K | 440.8K | -3% | -$3.11M |
| D | 2024-06-10 | 2024-06-07 | RMD | ResMed| | Farrell Michael J. | CEO | M - OptEx | $84.98 | +14.7K | 455.5K | +3% | +$1.25M |
| DM | 2024-05-09 | 2024-05-07 | RMD | ResMed| | Farrell Michael J. | CEO | M - OptEx | $84.98 | +14.7K | 455.4K | +3% | +$1.25M |
| D | 2024-05-09 | 2024-05-07 | RMD | ResMed| | Farrell Michael J. | CEO | S - Sale+OE | $216.50 | -14.7K | 440.8K | -3% | -$3.18M |
| DA | 2023-11-20 | 2023-11-16 | RMD | ResMed| | Farrell Michael J. | CEO | M - OptEx | $57.76 | +3,462 | 444.4K | +0.8% | +$200.0K |
| DMA | 2023-11-20 | 2023-11-16+ | RMD | ResMed| | Farrell Michael J. | CEO | F - Tax | $148.93 | -3,696 | 443.1K | -0.8% | -$550.4K |
| D | 2023-11-20 | 2023-11-20 | RMD | ResMed| | Farrell Michael J. | CEO | F - Tax | $148.94 | -2,353 | 438.6K | -0.5% | -$350.4K |
| D | 2023-11-16 | 2023-11-15 | RMD | ResMed| | Farrell Michael J. | CEO | S - Sale+OE | $152.04 | -5,678 | 441.0K | -1% | -$863.3K |
| D | 2023-11-16 | 2023-11-15 | RMD | ResMed| | Farrell Michael J. | CEO | M - OptEx | $57.76 | +5,678 | 446.7K | +1% | +$328.0K |
| M | 2023-11-15 | 2023-11-13 | RMD | ResMed| | Farrell Michael J. | CEO | F - Tax | $143.60 | -8,452 | 446.2K | -2% | -$1.21M |
| D | 2023-10-17 | 2023-10-16 | RMD | ResMed| | Farrell Michael J. | CEO | S - Sale+OE | $140.70 | -5,675 | 449.4K | -1% | -$798.5K |
| D | 2023-10-17 | 2023-10-16 | RMD | ResMed| | Farrell Michael J. | CEO | M - OptEx | $57.76 | +5,675 | 455.0K | +1% | +$327.8K |
| D | 2023-09-19 | 2023-09-15 | RMD | ResMed| | Farrell Michael J. | CEO | M - OptEx | $57.76 | +5,675 | 455.0K | +1% | +$327.8K |
| D | 2023-09-19 | 2023-09-15 | RMD | ResMed| | Farrell Michael J. | CEO | S - Sale+OE | $146.35 | -5,675 | 449.4K | -1% | -$830.5K |
| 2023-08-18 | 2023-08-17 | RMD | ResMed| | Farrell Michael J. | CEO | A - Grant | $0.00 | +12.4K | 449.4K | +3% | $0 | |
| D | 2023-08-17 | 2023-08-15 | RMD | ResMed| | Farrell Michael J. | CEO | S - Sale+OE | $183.20 | -5,675 | 436.9K | -1% | -$1.04M |
| D | 2023-08-17 | 2023-08-15 | RMD | ResMed| | Farrell Michael J. | CEO | M - OptEx | $57.76 | +5,675 | 442.6K | +1% | +$327.8K |
| D | 2023-07-19 | 2023-07-17 | RMD | ResMed| | Farrell Michael J. | CEO | S - Sale+OE | $221.27 | -5,675 | 436.9K | -1% | -$1.26M |
| D | 2023-07-19 | 2023-07-17 | RMD | ResMed| | Farrell Michael J. | CEO | M - OptEx | $57.76 | +5,675 | 442.6K | +1% | +$327.8K |
| D | 2023-06-16 | 2023-06-15 | RMD | ResMed| | Farrell Michael J. | CEO | M - OptEx | $57.76 | +5,675 | 442.6K | +1% | +$327.8K |
| D | 2023-06-16 | 2023-06-15 | RMD | ResMed| | Farrell Michael J. | CEO | S - Sale+OE | $217.39 | -5,675 | 436.9K | -1% | -$1.23M |
| D | 2023-05-17 | 2023-05-15 | RMD | ResMed| | Farrell Michael J. | CEO | M - OptEx | $57.76 | +5,675 | 442.6K | +1% | +$327.8K |
| D | 2023-05-17 | 2023-05-15 | RMD | ResMed| | Farrell Michael J. | CEO | S - Sale+OE | $232.10 | -5,675 | 436.9K | -1% | -$1.32M |
| D | 2023-04-18 | 2023-04-17 | RMD | ResMed| | Farrell Michael J. | CEO | S - Sale+OE | $224.23 | -5,675 | 436.9K | -1% | -$1.27M |
| D | 2023-04-18 | 2023-04-17 | RMD | ResMed| | Farrell Michael J. | CEO | M - OptEx | $57.76 | +5,675 | 442.6K | +1% | +$327.8K |
| D | 2023-03-17 | 2023-03-15 | RMD | ResMed| | Farrell Michael J. | CEO | M - OptEx | $57.76 | +5,675 | 442.6K | +1% | +$327.8K |
| D | 2023-03-17 | 2023-03-15 | RMD | ResMed| | Farrell Michael J. | CEO | S - Sale+OE | $206.95 | -5,675 | 436.9K | -1% | -$1.17M |
| D | 2023-02-16 | 2023-02-15 | RMD | ResMed| | Farrell Michael J. | CEO | M - OptEx | $57.76 | +5,675 | 442.6K | +1% | +$327.8K |
| D | 2023-02-16 | 2023-02-15 | RMD | ResMed| | Farrell Michael J. | CEO | S - Sale+OE | $214.83 | -5,675 | 436.9K | -1% | -$1.22M |
| D | 2023-01-18 | 2023-01-17 | RMD | ResMed| | Farrell Michael J. | CEO | M - OptEx | $57.76 | +5,675 | 442.6K | +1% | +$327.8K |
| D | 2023-01-18 | 2023-01-17 | RMD | ResMed| | Farrell Michael J. | CEO | S - Sale+OE | $224.36 | -5,675 | 436.9K | -1% | -$1.27M |
| D | 2022-12-16 | 2022-12-15 | RMD | ResMed| | Farrell Michael J. | CEO | M - OptEx | $57.76 | +5,675 | 442.6K | +1% | +$327.8K |
| D | 2022-12-16 | 2022-12-15 | RMD | ResMed| | Farrell Michael J. | CEO | S - Sale+OE | $215.63 | -5,675 | 436.9K | -1% | -$1.22M |
| 2022-11-23 | 2022-11-23 | RMD | ResMed| | Farrell Michael J. | CEO | A - Grant | $0.00 | +56.1K | 470.1K | +14% | $0 | |
| 2022-11-23 | 2022-11-23 | RMD | ResMed| | Farrell Michael J. | CEO | F - Tax | $224.40 | -33.2K | 436.9K | -7% | -$7.46M | |
| D | 2022-11-16 | 2022-11-15 | RMD | ResMed| | Farrell Michael J. | CEO | S - Sale+OE | $224.64 | -5,675 | 414.0K | -1% | -$1.27M |
| D | 2022-11-16 | 2022-11-15 | RMD | ResMed| | Farrell Michael J. | CEO | M - OptEx | $57.76 | +5,675 | 419.7K | +1% | +$327.8K |
| M | 2022-11-15 | 2022-11-11 | RMD | ResMed| | Farrell Michael J. | CEO | F - Tax | $225.18 | -8,630 | 414.0K | -2% | -$1.94M |
| MI | 2022-11-14 | 2022-11-10 | RMD | ResMed| | Farrell Michael J. | CEO | G - Gift | $0.00 | 0 | 4,090 | New | $0 |
| I | 2022-11-14 | 2022-11-10 | RMD | ResMed| | Farrell Michael J. | CEO | S - Sale | $220.83 | -4,880 | 0 | -100% | -$1.08M |
| D | 2022-10-18 | 2022-10-17 | RMD | ResMed| | Farrell Michael J. | CEO | M - OptEx | $57.76 | +5,675 | 428.2K | +1% | +$327.8K |
| D | 2022-10-18 | 2022-10-17 | RMD | ResMed| | Farrell Michael J. | CEO | S - Sale+OE | $214.58 | -5,675 | 422.6K | -1% | -$1.22M |
Purchase Sale Sale after option exercise All abbreviations